Lilly PACKAGE LABEL - Zepbound Multi-Dose Vial - 15 mg/0.6 mL Dose (60 mg/2.4 mL [25 mg/mL]) Rx Only NDC 0002-6612-11 Zepbound (tirzepatide) injection 60 mg/2.4 mL (25 mg/mL) ATTENTION: Contains 4 doses of 15 mg/0.6 mL 2.4 mL MULTI-DOSE VIAL For Subcutaneous Use Needles and Syringes are not included Dispense enclosed Medication Guide to each patient
50mg Hilfsstoffe
Your provider will increase your dose every 4 weeks through 0.5 mg, 1.0 mg, 1.7 mg, and potentially 2.4 mg based on your response and side effect tolerance
In summary, we have presented a robust and flexible tool for live-cell GSH imaging that we used to observe the compartmentalization and fluctuation of cellular GSH
As an additional analysis, changes in weight and HbA1c, including the composite weight and HbA1c outcomes, were compared over the follow-up period in the following patient subgroups: persistentpatients who were persistent to the index therapy (defined as patients with 60 days gap in supply)
Supporting the Immune System Your immune cells are highly sensitive to their environment